CTOs on the Move

Respicardia

www.respicardia.com

 
Founded in 2006 and headquartered near Minneapolis, Minnesota, Respicardia® is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve Respiratory Rhythm Management and cardiovascular health. The remedē® System is an innovative implantable stimulation device designed to restore natural breathing during sleep for patients with Central Sleep Apnea.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.respicardia.com
  • 12400 Whitewater Dr Suite 150
    Minnetonka, MN USA 55343
  • Phone: 952.540.4470

Executives

Name Title Contact Details

Funding

Respicardia raised $58.5M on 12/19/2017

Similar Companies

Soderberg Inc-Contact Lens Div

Soderberg Inc-Contact Lens Div is a Oak Creek, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SOUTHWEST MEDICAL CTR

SOUTHWEST MEDICAL CTR is a Lafayette, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

VentriFlo

The VentriFlo True Pulse Pump is a novel, truly pulsatile blood pumping system designed to achieve superior outcomes, reduce costs and improve safety for pediatric & adult patients who require cardiopulmonary support during surgery or in the ICU.

PESI

PESI is a Eau Claire, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

JEOL

JEOL USA, Inc. is a wholly owned subsidiary of JEOL, Ltd. of Akishima, Japan.JEOL USA, Inc. was incorporated in the United States in 1962, and moved to present corporate offices at 11 Dearborn Road in Peabody, Massachusetts, in August 1979. The primary